CFTR and exocrine pancreatic insufficiency: The antibody titer was highly variable, and a few subgroups of the population had lower responses, including patients aged ≥ 30 years, those with pancreatic insufficiency and P. aeruginosa infection, and patients regularly treated with systemic antibiotic, inhaled corticosteroids, or CFTR modulators.